Arecor Therapeutics PLC (AREC) — Working Capital to Net Assets Ratio
Arecor Therapeutics PLC (AREC) has a Working Capital to Net Assets ratio of 85.6% as of June 2025. Working capital of GBX2.45 Million (current assets of GBX4.77 Million minus current liabilities of GBX2.33 Million) is measured against net assets of GBX2.86 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AREC equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Arecor Therapeutics PLC Working Capital to Net Assets (2017–2024)
This chart shows how Arecor Therapeutics PLC's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 85.6%, reflecting working capital of GBX2.45 Million against net assets of GBX2.86 Million GBX. Check Arecor Therapeutics PLC (AREC) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Arecor Therapeutics PLC (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Arecor Therapeutics PLC from 2017 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Arecor Therapeutics PLC (AREC) total market value.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 93.1% | GBX4.98 Million | GBX5.35 Million | GBX8.23 Million | GBX3.26 Million | ▲ +29.9 pp |
| 2023 | 63.2% | GBX6.02 Million | GBX9.53 Million | GBX11.17 Million | GBX5.15 Million | ▼ -15.6 pp |
| 2022 | 78.8% | GBX13.75 Million | GBX17.45 Million | GBX17.48 Million | GBX3.73 Million | ▼ -19.6 pp |
| 2021 | 98.4% | GBX18.25 Million | GBX18.55 Million | GBX20.52 Million | GBX2.27 Million | ▼ -213.6 pp |
| 2020 | 312.0% | GBX2.41 Million | GBX773.79K | GBX3.82 Million | GBX1.41 Million | ▲ +222.2 pp |
| 2019 | 89.7% | GBX2.88 Million | GBX3.21 Million | GBX3.92 Million | GBX1.04 Million | ▼ -2.6 pp |
| 2019 | 92.3% | GBX3.89 Million | GBX4.22 Million | GBX5.00 Million | GBX1.11 Million | ▼ -11.7 pp |
| 2018 | 104.0% | GBX697.13K | GBX670.33K | GBX1.52 Million | GBX823.30K | ▲ +33.6 pp |
| 2017 | 70.4% | GBX937.42K | GBX1.33 Million | GBX1.90 Million | GBX958.55K | — |